2-氯-5-(吡咯烷-1-磺酰基)-吡啶 | 64614-51-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 2-氯-5-(吡咯烷-1-磺酰基)-吡啶
• 英文名称: 2-chloro-5-(pyrrolidin-1-ylsulfonyl)pyridine
• 英文别名: 2-chloro-5-(1-pyrrolidinylsulfonyl)pyridine；2-chloro-5-pyrrolidin-1-ylsulfonylpyridine
• CAS: 64614-51-3
• 化学式: C₉H₁₁ClN₂O₂S
• mdl: MFCD03988229
• 分子量: 246.718
• InChiKey: HBZKJCDPAUHBFB-UHFFFAOYSA-N

物化性质

• 溶解度：
  >37 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.444
• 拓扑面积：
  58.6
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2935009090

反应信息

• 作为反应物：
  描述：

  2-氯-5-(吡咯烷-1-磺酰基)-吡啶 在 三甲基氯硅烷 、 sodium hydride 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 28.67h， 生成
  参考文献：
  名称：

  High Throughput Synthesis of Extended Pyrazolo[3,4-d]dihydropyrimidines

  摘要：

  Thirteen 5-hetarylaminopyrazoles were synthesized in 62-93% yield through the arylation of 1-isopropyl- and 1-phenyl-5-aminopyrazoles with electrophilic hetarylhalides under optimized conditions. Condensation of 5-hetarylaminopyrazoles with carbonyl compounds facilitated by AcOH or Me3SiCl furnished 23 pyrazolo[3,4-d]dihydropyrimidines in 69-86% yield. The target compounds were isolated through simple crystallization. The scope and limitation of the method are discussed.

  DOI：

  10.1021/co300063x
• 作为产物：
  描述：

  四氢吡咯 、 2-氯吡啶-5-磺酰氯 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 16.0h， 以69%的产率得到2-氯-5-(吡咯烷-1-磺酰基)-吡啶
  参考文献：
  名称：

  [EN] NEW SELECTIVE MODULATORS OF INSECT NICOTINIC ACETYLCHOLINE RECEPTORS
  [FR] NOUVEAUX MODULATEURS SÉLECTIFS DES RÉCEPTEURS NICOTINIQUES DE L'ACÉTYLCHOLINE D'INSECTES

  摘要：

  本发明涉及具有以下式（I）的化合物：其中：- A是由5至10个碳原子组成的（杂）芳基基团，可能被来自以下组的至少一个取代基取代：卤原子，氨基，叠氮基，氰基，硝基，羟基，甲酰基，羧基，酰胺基，（C1-C6）烷基基团，卤代（C1-C6）烷基基团，（C1-C6）氧烷基基团，烯基基团，环烯基基团和炔基基团，- R是H，CN或CF3，或它们的药学上可接受的盐，拉克米，对映体或对映异构体。

  公开号：

  WO2020094754A1

文献信息

• PYRROLOPYRIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS
  申请人：Bamborough Paul

  公开号：US20100179139A1

  公开（公告）日：2010-07-15

  The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds according to formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular IKK2 activity.

  本发明涉及某些新型化合物。具体而言，本发明涉及根据公式（I）的化合物及其盐。本发明的化合物是激酶活性抑制剂，特别是IKK2活性抑制剂。
• NEW SELECTIVE MODULATORS OF INSECT NICOTINIC ACETYLCHOLINE RECEPTORS
  申请人：Universite de Nantes

  公开号：EP3650447A1

  公开（公告）日：2020-05-13

  The present invention relates to a compound having the following formula (I): wherein: - A is a (hetero)aryl radical comprising from 5 to 10 carbon atoms, possibly substituted by at least one substituent chosen from the group consisting of: halogen atoms, amino, azido, cyano, nitro, hydroxyl, formyl, carboxyl, amido, (C1-C6)alkyl groups, halo(C1-C6)alkyl groups, (C1-C6)alkoxy groups, alkenyl groups, cycloalkenyl groups, and alkynyl groups, and - R is H, CN or CF3, or their pharmaceutically acceptable salts, racemates, diastereomers or enantiomers.

  本发明涉及一种具有下式 (I) 的化合物： 其中 - A 是由 5 至 10 个碳原子组成的(杂)芳基，可能被至少一个取代基取代，该取代基选 自以下组成的组：卤素原子、氨基、叠氮基、氰基、硝基、羟基、甲酰基、羧基、 氨基、(C1-C6)烷基、卤代(C1-C6)烷基、(C1-C6)烷氧基、烯基、环烯基和炔基，以及 - R 是 H、CN 或 CF3、 或它们的药学上可接受的盐、外消旋体、非对映异构体或对映体。
• WO2008/145688
  申请人：——

  公开号：——

  公开（公告）日：——
• Inhibition of cancer cell invasion by new ((3,4-dihydroxy benzylidene)hydrazinyl)pyridine-3-sulfonamide analogs
  作者：Seong-Mook Kang、Ky-Youb Nam、Seung-Youn Jung、Kyung-Hee Song、Seongho Kho、Kyoung Tai No、Hyun Kyung Choi、Jie-Young Song

  DOI：10.1016/j.bmcl.2015.12.093

  日期：2016.2

  Rab GTPases regulate various types of intracellular membrane trafficking in all eukaryotes. Since Rab27a and its multiple effectors are involved in exocytosis of lysosome-related organelles and play a major role in malignancy, compounds targeting Rab27a could be likely used to inhibit invasive growth and tumor metastasis. Thus, we designed and synthesized several compounds based on the previously reported Rab27a-targeting synthetic compounds identified by virtual screening, and investigated their anti-metastatic effects in MDA-MB231 and A375 cells. Among the synthesized compounds, (E)-N-(3-chlorophenyl)-6-(2-(3,4-dihydroxy benzylidene)hydrazinyl)pyridine-3-sulfonamide (3d) and (E)-N-benzyl-6-(2-(3,4-dihydroxy benzylidene)hydrazinyl)-N-methylpyridine-3-sulfonamide (3f) significantly inhibited the invasiveness of both tumor cell lines. Compounds 3d and 3f also decreased the levels of signature extracellular matrix marker proteins (fibronectin, collagen, and a-smooth muscle actin) and representative mesenchymal cell markers (N-cadherin and vimentin). Taken together, our results suggest that novel sulfonamide analogs have anti-metastatic activity in breast and melanoma cancer cell lines and may be used as therapeutic agents to treat malignant cancer. (C) 2016 Elsevier Ltd. All rights reserved.
• THUNUS L., ANN. PHARM. FRANC., 1977, 35, NO 5-6, 197-203
  作者：THUNUS L.

  DOI：——

  日期：——